- Home
- VRNA vs GFF Comparison
VRNA vs GFF Comparison
Compare VRNA & GFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNA
- GFF
- Stock Information
- Founded
- VRNA 2005
- GFF 1959
- Country
- VRNA United Kingdom
- GFF United States
- Employees
- VRNA N/A
- GFF N/A
- Industry
- VRNA Biotechnology: Pharmaceutical Preparations
- GFF Building Products
- Sector
- VRNA Health Care
- GFF Industrials
- Exchange
- VRNA Nasdaq
- GFF Nasdaq
- Market Cap
- VRNA 3.4B
- GFF 3.6B
- IPO Year
- VRNA 2017
- GFF N/A
- Fundamental
- Price
- VRNA $51.89
- GFF $76.62
- Analyst Decision
- VRNA Strong Buy
- GFF Strong Buy
- Analyst Count
- VRNA 7
- GFF 4
- Target Price
- VRNA $50.57
- GFF $89.25
- AVG Volume (30 Days)
- VRNA 1.4M
- GFF 415.6K
- Earning Date
- VRNA 02-27-2025
- GFF 02-05-2025
- Dividend Yield
- VRNA N/A
- GFF 0.94%
- EPS Growth
- VRNA N/A
- GFF 197.89
- EPS
- VRNA N/A
- GFF 4.23
- Revenue
- VRNA $5,624,000.00
- GFF $2,623,520,000.00
- Revenue This Year
- VRNA N/A
- GFF $0.93
- Revenue Next Year
- VRNA $550.30
- GFF $3.10
- P/E Ratio
- VRNA N/A
- GFF $18.11
- Revenue Growth
- VRNA 1127.95
- GFF N/A
- 52 Week Low
- VRNA $11.39
- GFF $55.01
- 52 Week High
- VRNA $55.42
- GFF $86.73
- Technical
- Relative Strength Index (RSI)
- VRNA 64.25
- GFF 58.34
- Support Level
- VRNA $43.44
- GFF $74.87
- Resistance Level
- VRNA $55.42
- GFF $77.02
- Average True Range (ATR)
- VRNA 3.32
- GFF 1.84
- MACD
- VRNA 0.40
- GFF 0.61
- Stochastic Oscillator
- VRNA 70.52
- GFF 90.11
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
About GFF Griffon Corporation
Griffon Corp manufactures and markets residential, commercial and industrial garage doors to professional installing dealers and home center retail chains. It also provides non-powered landscaping products for homeowners and professionals. Its operating segments include Consumer and Professional Products and Home and Building Products. The company generates a majority of its revenue from the Home and Building Products segment.